Features
News roundups
Announcements
Most Viewed      Most Discussed

Paying people to stop smoking is a very effective method of getting them to quit, a large review of studies has found

Quick Read

As someone who has lived with spinal muscular atrophy for all 30 years of my life, I was perplexed and disappointed that the recent approval of Novartis’ gene therapy Zolgensma was immediately overshadowed by outrage over the drug’s price: $2.125 million

Quick Read

Pfizer, one of the world’s largest drug companies, announced over the weekend that it would stop work on new drugs to fight Alzheimer’s disease and Parkinson’s disease. The reason? Pfizer believes that research on the two diseases doesn’t make sense financially

Quick Read

Sometimes doctors choose to do surgery not because it is absolutely preferable to other treatments but because they get reimbursed for it, a new study suggests

Quick Read

Susan Fredriksen: “It took me about two months to fully recuperate, but it was worth it. When I decided to donate my kidney, it wasn’t much of a decision-making process, but more like a tap on the shoulder.”

Quick Read

There are lots of ways to make a buck, but becoming a human guinea pig for drug research has to be one of the oddest. “We are selling our bodies, most definitely,” says Paul Clough, who has taken part in more than 80 drug tests in the past 11 years

Quick Read

After one of her operations, my sister-in-law left the hospital so quickly that she couldn’t eat for days; after other stays, she wasn’t discharged until she felt physically and mentally prepared. Five days after his triple heart bypass surgery, my stepfather felt well enough to go home, but the hospital didn’t discharge him for several more days

Quick Read

The public overwhelmingly supports Medicare’s plan to pay for end-of-life discussions between doctors and patients, despite GOP objections that such chats would lead to rationed care for the elderly and ill, a poll released Wednesday finds

Quick Read